Chronic Kidney Disease is when the kidneys gradually get damaged over time and the kidneys are unable to complete functions such as removing wastes from your body, maintain blood pressure, and keeping your bones healthy.
Looking Ahead: Post-COVID Resources
Resources for anticipating and navigating a post-pandemic world.
-
Biden Administration Invests $20 Million in Telehealth Services
-
NIH Grants $470 Million to Study Long-Term Effects of COVID-19
-
PBMs Shifted to Virtual Audits During Pandemic, Placing More Strain on Independent Pharmacists.
-
New Long-Haul COVID Clinics Treat Mysterious and Ongoing Symptoms
-
How COVID-19 Healthcare is Raising the Bar for Interoperability
-
AI Collaboration Saves Pharmacies 5.5 Hours Monthly on Critical Administrations Tasks
-
Digital Healthcare: Contactless Payments in a Post-COVID World
-
Return to Business During a Pandemic: Market Collaboration and Health Benefit Trends
-
Early Impact of CMS Expansion of Medicare Telehealth During COVID-19
-
Forecasting COVID-19 with Predictive Analytics, Big Data Tools
-
60% of Patients Interested in Using Digital Communication Tools
-
COVID-19 Hospitalizations Could Mean High Out-of-Pocket Medical Costs for Many Americans
-
Enter AI: How Technology is Changing the Pharmaceutical Industry for the Better
-
CMS: Value-Based Reimbursement Key to Addressing Health Disparities
-
State Efforts to Expand Medicaid Coverage & Access to Telehealth in Response to COVID-19
-
Crisis Into Opportunity: Can COVID-19 Help Set a Path to Improved Health Care Efficiency?
-
MedPAC Urges MA, ACO Tweaks to Speed Up Value-Based Payment Reform
-
Re-examining the Delivery of High-Value Care through COVID-19
-
Many Happy Returns: A Systematic Approach to Bringing Employees Back
-
Implementing Lowest Unit of Measure Concepts to Supply Chain Can Help Offset COVID-19 Cost
-
Telehealth Could Grow to a $250B Revenue Opportunity Post-COVID-19: Analysis
-
COVID-19 Will Have Lasting Changes in the Way Local Pharmacies Operate
-
3D-Printed Drugs Could Be a Godsend for Those on Multiple Pills a Day – and Potentially Life Saving
-
Brookings Report: Removing Regulatory Barriers to Telehealth
-
9 Ways Covid-19 May Forever Upend the U.S. Health Care Industry
- COVID-19 and Post-infection Immunity: Limited Evidence, Many Remaining Questions
- What Will U.S. Health Care Look Like After the Pandemic?
-
Social Distancing Could Last Months, White House Coronavirus Coordinator Says
-
Telehealth Will Be Free, No Copays, They Said. But Patients Are Getting Billed
Related
Prescription Digital Therapeutics (PDTs) offer vast opportunities but require careful consideration for coverage and reimbursement. At the direction of the AMCP Board of Directors we have developed definitions and principles to simplify your decision-making and provide digital health innovators with essential insights for evaluating safety and efficacy.
The United States Pharmacopeia Convention (USP) and the United States Food and Drug Administration (FDA) have updated an educational resource on biosimilars to help healthcare practitioners improve patient confidence in the quality and effectiveness of these treatment options. The following are recommended social media, website, and email content you can use to share this resource with your network.
Featured News & Resources
See Full Calendar
Other Events
HBCU Travel Awards for AMCP25
Other Events
Mid-South AMCP Day of Education 2025
Other Events
Southwest AMCP Annual Day of Education 2025
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
